TN SB2246 | 2023-2024 | 113th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 30 2024 - 25% progression
Action: 2024-04-22 - Companion House Bill substituted
Text: Latest bill text (Draft #1) [PDF]
Status: Introduced on January 30 2024 - 25% progression
Action: 2024-04-22 - Companion House Bill substituted
Text: Latest bill text (Draft #1) [PDF]
Summary
As introduced, requires health-related boards that license practitioners authorized to prescribe buprenorphine-containing products to post nonresidential buprenorphine guidelines and standards on the licensing board's website no more than 10 days after receipt of the guidelines. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
Title
AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63 and Title 68, relative to buprenorphine.
Sponsors
| Sen. Art Swann [R] |
Roll Calls
2024-04-03 - Senate - SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 7, Nays 2 PNV 0 (Y: 7 N: 2 NV: 0 Abs: 0) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-04-22 | Senate | Companion House Bill substituted |
| 2024-04-19 | Senate | Placed on Senate Regular Calendar for 4/22/2024 |
| 2024-04-03 | Senate | Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 7, Nays 2 PNV 0 |
| 2024-03-27 | Senate | Placed on Senate Health and Welfare Committee calendar for 4/3/2024 |
| 2024-03-20 | Senate | Reset on Final calendar of Senate Health and Welfare Committee |
| 2024-03-13 | Senate | Placed on Senate Health and Welfare Committee calendar for 3/19/2024 |
| 2024-02-01 | Senate | Passed on Second Consideration, refer to Senate Health and Welfare Committee |
| 2024-01-31 | Senate | Introduced, Passed on First Consideration |
| 2024-01-30 | Senate | Filed for introduction |
Same As/Similar To
HB2093 (Crossfiled) 2024-05-10 - Transmitted to Governor for his action.
